158 related articles for article (PubMed ID: 25677901)
1. Identification of peptide regions of SERPINA1 and ENOSF1 and their protein expression as potential serum biomarkers for gastric cancer.
Yang J; Xiong X; Wang X; Guo B; He K; Huang C
Tumour Biol; 2015 Jul; 36(7):5109-18. PubMed ID: 25677901
[TBL] [Abstract][Full Text] [Related]
2. Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma.
Yang J; Yang J; Gao Y; Zhao L; Liu L; Qin Y; Wang X; Song T; Huang C
PLoS One; 2014; 9(11):e111364. PubMed ID: 25368985
[TBL] [Abstract][Full Text] [Related]
3. [Screen and identification of serum protein biomarkers in gastric cancer].
Zhang H; Li H; Guo F; Zhang D; Yang H; Wang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Mar; 19(3):317-22. PubMed ID: 27003656
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel low molecular weight serum peptidome biomarkers for non-small cell lung cancer (NSCLC).
Yang J; Song YC; Song TS; Hu XY; Guo YM; Li ZF; Dang CX; Huang C
J Clin Lab Anal; 2012 May; 26(3):148-54. PubMed ID: 22628229
[TBL] [Abstract][Full Text] [Related]
5. Differential expression and clinical significance of serum protein among patients with clear-cell renal cell carcinoma.
Nuerrula Y; Rexiati M; Liu Q; Wang YJ
Cancer Biomark; 2015; 15(4):485-91. PubMed ID: 26406868
[TBL] [Abstract][Full Text] [Related]
6. Serum peptide mapping in gastric precancerous lesion and cancer.
Li P; Ma D; Zhu ST; Tang XD; Zhang ST
J Dig Dis; 2014 May; 15(5):239-45. PubMed ID: 24438315
[TBL] [Abstract][Full Text] [Related]
7. Identification of carboxyl terminal peptide of Fibrinogen as a potential serum biomarker for gastric cancer.
Wu C; Luo Z; Tang D; Liu L; Yao D; Zhu L; Wang Z
Tumour Biol; 2016 May; 37(5):6963-70. PubMed ID: 26662807
[TBL] [Abstract][Full Text] [Related]
8. Proteomic identification of serum biomarkers for gastric cancer using multi-dimensional liquid chromatography and 2D differential gel electrophoresis.
Liu W; Liu B; Cai Q; Li J; Chen X; Zhu Z
Clin Chim Acta; 2012 Jul; 413(13-14):1098-106. PubMed ID: 22446497
[TBL] [Abstract][Full Text] [Related]
9. Classification of Epidermal Growth Factor Receptor Gene Mutation Status Using Serum Proteomic Profiling Predicts Tumor Response in Patients with Stage IIIB or IV Non-Small-Cell Lung Cancer.
Yang L; Tang C; Xu B; Wang W; Li J; Li X; Qin H; Gao H; He K; Song S; Liu X
PLoS One; 2015; 10(6):e0128970. PubMed ID: 26047516
[TBL] [Abstract][Full Text] [Related]
10. Proteomics-based identification of a tumor-associated antigen and its corresponding autoantibody in gastric cancer.
Tsunemi S; Nakanishi T; Fujita Y; Bouras G; Miyamoto Y; Miyamoto A; Nomura E; Takubo T; Tanigawa N
Oncol Rep; 2010 Apr; 23(4):949-56. PubMed ID: 20204278
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel serum biomarkers for gastric cancer by magnetic bead.
Liu W; Gao X; Cai Q; Li J; Zhu Z; Li C; Yao X; Yang Q; Xiang M; Yan M; Zhu Z
Front Biosci (Elite Ed); 2010 Jun; 2(3):961-71. PubMed ID: 20515767
[TBL] [Abstract][Full Text] [Related]
12. Identification of 2 serum biomarkers of renal cell carcinoma by surface enhanced laser desorption/ionization mass spectrometry.
Hara T; Honda K; Ono M; Naito K; Hirohashi S; Yamada T
J Urol; 2005 Oct; 174(4 Pt 1):1213-7. PubMed ID: 16145372
[TBL] [Abstract][Full Text] [Related]
13. [Identification of biomarkers in the serum of the patients with poorly differentiated gastric cancer].
Li W; Liu BY; Li JF; Chen XH; Hao JH; Cai Q; Gu QL; Zhu ZG; Lin YZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 May; 9(3):253-6. PubMed ID: 16721691
[TBL] [Abstract][Full Text] [Related]
14. Identification of macrophage migration inhibitory factor and human neutrophil peptides 1-3 as potential biomarkers for gastric cancer.
Mohri Y; Mohri T; Wei W; Qi YJ; Martin A; Miki C; Kusunoki M; Ward DG; Johnson PJ
Br J Cancer; 2009 Jul; 101(2):295-302. PubMed ID: 19550422
[TBL] [Abstract][Full Text] [Related]
15. Mining novel biomarkers for prognosis of gastric cancer with serum proteomics.
Qiu FM; Yu JK; Chen YD; Jin QF; Sui MH; Huang J
J Exp Clin Cancer Res; 2009 Sep; 28(1):126. PubMed ID: 19740432
[TBL] [Abstract][Full Text] [Related]
16. MALDI-TOF-MS analysis in low molecular weight serum peptidome biomarkers for NSCLC.
Song Y; Xu X; Wang N; Zhang T; Hu C
J Clin Lab Anal; 2022 Apr; 36(4):e24254. PubMed ID: 35212031
[TBL] [Abstract][Full Text] [Related]
17. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.
Lu HB; Zhou JH; Ma YY; Lu HL; Tang YL; Zhang QY; Zhao CH
Jpn J Clin Oncol; 2010 Apr; 40(4):336-42. PubMed ID: 20089528
[TBL] [Abstract][Full Text] [Related]
18. Proteomics analysis of human serum of patients with non-small-cell lung cancer reveals proteins as diagnostic biomarker candidates.
Boccellino M; Pinto F; Ieluzzi V; Giovane A; Quagliuolo L; Fariello C; Coppola M; Carlucci A; Santini M; Ferati K; Bexheti-Ferati A; Giordano A; Di Domenico M
J Cell Physiol; 2019 Dec; 234(12):23798-23806. PubMed ID: 31180588
[TBL] [Abstract][Full Text] [Related]
19. Identification of α1-antitrypsin as a potential prognostic biomarker for advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors by proteomic analysis.
Zhao W; Yang Z; Liu X; Tian Q; Lv Y; Liang Y; Li C; Gao X; Chen L
J Int Med Res; 2013 Jun; 41(3):573-83. PubMed ID: 23613495
[TBL] [Abstract][Full Text] [Related]
20. Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors.
Gianazza E; Chinello C; Mainini V; Cazzaniga M; Squeo V; Albo G; Signorini S; Di Pierro SS; Ferrero S; Nicolardi S; van der Burgt YE; Deelder AM; Magni F
J Proteomics; 2012 Dec; 76 Spec No.():125-40. PubMed ID: 22868251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
